G-MAX GIRDER ASSEMBLY STANDS OUT FOR EASE OF INSTALLATION

As the premier manufacturer of high-grade steel solar mounting systems, Schletter offers the next generation of racking with G-Max. G-Max’s fixed-tilt construction is ideally suited for utility-scale installations, and exceptional ease-of-assembly in the field and competitive pricing distinguish this American-made steel mounting system from their competitors. In fact, widely recognized for its thoughtful, streamlined design and components that are known for their strength and safety, the G-Max system’s fast and easy installation is so simple that a single person can install the girder, head adapter, and strut without assistance. This week’s Schletter how-to video focuses on the G-Max Girder Assembly’s ease-of-installation, and the following steps outline how simple the clear-cut girder assembly process is.

G-Max Installation: Single Person Girder Assembly steps:

  1. Position the strut onto previously installed lower location bolt.
  2. Position head into upper location bolt.
  3. Install bolt at upper post.
  4. Tighten post bolts using 19 mm socket. The post will pull in tightly.
  5. Mark all the tightened bolts for quality control.

By pre-assembling many components prior to shipment, allowing installers to unfold and connect the structure more easily on site, Schletter is changing the way the solar industry views steel solar mounting products. And with benefits that include increased adjustment capability in the field, increased spans between foundations, standardization and reduction of hardware, and lower costs across multiple installation steps, G-Max is revolutionizing the steel, fixed-filt industry, saving customers both time and money. G-Max also comes with a 20-year limited warranty, providing every Schletter customer with peace of mind.

For other G-Max Installation videos addressing topics such as post installation, purlin layout, purlin alignment, and module and clamp installation, check out www.schletter.us/gmax to learn more.

Source / learn more Youtube

Read more at schletter.us

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More